Related Experiment Videos
Sentinel node localization and biopsy in breast cancer
1Royal Free Hospital School of Medicine, London, UK.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|June 23, 1999
Summary
Sentinel lymph node biopsy using lymphoscintography can help identify breast cancer patients who do not require full axillary lymph node dissection, reducing unnecessary side effects. This minimally invasive technique shows promising results in early-stage cancer detection.
Area of Science:
- Oncology
- Surgical Oncology
- Diagnostic Imaging
Background:
- Routine axillary lymph node dissection (ALND) is standard for primary breast tumors.
- Increasing early-stage breast cancer diagnoses make ALND unnecessary for some patients.
- ALND carries risks; identifying patients who need it is crucial.
Purpose of the Study:
- To evaluate sentinel lymph node biopsy (SLNB) using lymphoscintography as an alternative to ALND.
- To accurately predict axillary lymph node status in breast cancer patients.
- To determine the necessity of ALND based on sentinel node status.
Main Methods:
- Sentinel lymph node localization via lymphoscintography.
- Biopsy of the identified sentinel lymph node/s.
- Comparison with axillary lymph node dissection outcomes.
Main Results:
- Encouraging results observed during the trial period.
- SLNB accurately predicts axillary disease status in a subset of patients.
- Potential to avoid unnecessary ALND in eligible patients.
Conclusions:
- Sentinel lymph node biopsy is a promising alternative to routine ALND for selected breast cancer patients.
- This technique can help minimize treatment-related morbidity.
- Further multi-center trials are validating its efficacy and safety.